Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis

被引：0
|
作者：
Mitsani, D. [1 ]
Nguyen, H. [1 ]
Shields, R. [1 ]
Toyoda, Y. [1 ]
Bhama, J. [1 ]
Kwak, E. [1 ]
Silveira, F. [1 ]
Pilewski, J. [1 ]
Crespo, M. [1 ]
Clancy, C. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2011年 / 30卷 / 04期
关键词：
D O I：
10.1016/j.healun.2011.01.112
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [41] Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Gotta, Verena
    Royston, Eva
    Pressacco-Brossier, Caroline
    Aad, Yasmine Abi
    Tonoli, David
    Karmime, Abderrahim
    Jayo, Murielle
    Van Delden, Christian
    Lescuyer, Pierre
    Pfister, Marc
    Chalandon, Yves
    Neofytos, Dionysios
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (08)
  • [42] Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States
    D'Arcy, Monica E.
    Pfeiffer, Ruth M.
    Rivera, Donna R.
    Hess, Gregory P.
    Cahoon, Elizabeth K.
    Arron, Sarah T.
    Brownell, Isaac
    Cowen, Edward W.
    Israni, Ajay K.
    Triplette, Matthew A.
    Yanik, Elizabeth L.
    Engels, Eric A.
    JAMA DERMATOLOGY, 2020, 156 (07) : 772 - 779
  • [43] Voriconazole and Cutaneous Squamous Cell Carcinoma Risk among Lung Transplant Recipients
    D'Arcy, Monica
    Pfeiffer, Ruth
    Rivera, Donna R.
    Aaron, Sarah
    Yanik, Elizabeth
    Brownell, Isaac
    Cowen, Edward
    Triplette, Matthew
    Hess, Greg
    Engels, Eric A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 43 - 43
  • [44] Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole
    Mattner, F
    Chaberny, IF
    Weissbrodt, H
    Fischer, S
    Gastmeier, P
    Haubitz, B
    Gottlieb, J
    Mattner, L
    Strueber, M
    MYCOSES, 2005, 48 : 51 - 55
  • [45] Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis
    Sayah, D. M.
    Schwartz, B. S.
    Kukreja, J.
    Singer, J. P.
    Golden, J. A.
    Leard, L. E.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (02) : E70 - E74
  • [46] Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis
    Katada, Yoshiki
    Nakagawa, Shunsaku
    Nagao, Miki
    Yoshida, Yuko
    Matsuda, Yuya
    Yamamoto, Yuki
    Itohara, Kotaro
    Imai, Satoshi
    Yonezawa, Atsushi
    Nakagawa, Takayuki
    Matsubara, Kazuo
    Tanaka, Satona
    Nakajima, Daisuke
    Date, Hiroshi
    Terada, Tomohiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (01) : 54 - 60
  • [47] Effect of letermovir initiation on tacrolimus concentrations among lung transplant recipients receiving concomitant azole antifungal prophylaxis
    Goodlet, Kellie J.
    Garcia, Rhiannon
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (02)
  • [48] Voriconazole Therapeutic Drug Monitoring in a Pediatric Hematopoietic Stem Cell Transplant Center
    Kim, Abby
    Elder, Joshua
    Cheerva, Alexandra
    Lucas, Kenneth
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S368 - S368
  • [49] Therapeutic Drug Monitoring of Voriconazole in Children
    Chen, Jennifer
    Chan, Carol
    Colantonio, David
    Seto, Winnie
    THERAPEUTIC DRUG MONITORING, 2012, 34 (01) : 77 - 84
  • [50] Therapeutic Drug Monitoring of Voriconazole and Posaconazole
    Hussaini, Trana
    Rueping, Maria J. G. T.
    Farowski, Fedja
    Vehreschild, Janne J.
    Cornely, Oliver A.
    PHARMACOTHERAPY, 2011, 31 (02): : 214 - 225
12345